SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trading with high volatility as retail investors debate the company's Cybercab launch event, with many expressing frustration over the lack of a public livestream and divided on whether the event represents a "sell-the-news" moment or a significant catalyst for long-term autonomous technology. While bulls highlight the potential for robotaxi-driven growth and fleet scalability, bears point to regulatory scrutiny and the event's secrecy as signs of potential downside.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon Athletica is trading significantly lower after reporting disappointing quarterly results, marked by falling revenue and a sharp cut to its full-year guidance due to weaker-than-expected North American demand. The community is deeply divided, with many traders expressing skepticism about the brand's long-term viability amid increased competition, while some investors view the selloff as an overreaction and a potential buying opportunity for a turnaround.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as traders react to positive analyst coverage, including a price target hike from Morgan Stanley and momentum driven by interest in its prediction markets and the Robinhood Chain. While sentiment is largely bullish with some investors eyeing higher targets, debate continues regarding the impact of market manipulation and the asset's volatility compared to broader crypto trends.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending as traders analyze its recent financial results, which featured record quarterly revenue and a double beat against analyst estimates, though a softer outlook for the next quarter has spurred debate about contract timing and investment cycles. The conversation also highlights persistent optimism regarding the company's competitive moat in satellite imagery and its potential role in the defense and AI-driven geospatial intelligence markets.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is trending following a fiscal fourth-quarter earnings report where the company beat analyst estimates on top and bottom lines and issued guidance above projections. While some traders expressed bullish sentiment regarding the company's AI-driven security momentum, others voiced frustration over slowing growth in high-value customers and conservative forward guidance.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Traders are intensely debating Super Micro Computer's valuation, with bulls citing a perceived disconnect between strong fundamentals and the current price, while bears focus on corporate governance concerns and volatility. The conversation is dominated by comparisons to peers like Dell and HPE, as investors look for signs of a potential price breakout or squeeze.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending following a record-setting second-quarter earnings report that exceeded analyst expectations and saw the company raise its full-year guidance. Traders are also reacting to a surge in order backlogs driven by heightened global demand for missile systems, alongside news that the company is the frontrunner to acquire Ultra Maritime to bolster its naval and anti-submarine warfare portfolio.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is trending as retail traders debate the impact of the recently showcased Cybercab, with sentiments divided between optimism over Tesla's autonomous technology and concerns regarding the event's execution and potential 'sell-the-news' risks. The discussion is heavily centered on the stock's volatility and its use as a speculative instrument for short-term trading.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as traders debate its upcoming earnings report, with sentiment divided between those expecting an institutional short squeeze due to high short interest and those skeptical of the company's valuation and AI growth prospects. Investors are closely monitoring ARR guidance and management's commentary on agentic AI to determine if the stock's recent rally is justified.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

The community is discussing a leadership transition at Adobe, where Anil Chakravarthy will succeed Shantanu Narayen as CEO. While some traders view the internal promotion as a logical move to drive enterprise growth, others express skepticism and concern over the company's ability to compete with generative AI disruptions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Iovance Biotherapeutics is trending as investors anticipate upcoming guidance updates and clinical data milestones, following reports of a strategic life sciences delegation visit from the UAE to the company's manufacturing facility. The community remains focused on the potential for institutional accumulation and the long-term re-rating of its TIL therapy platform.

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen 

Halozyme, Repligen, Iovance, Arcutis and Precigen have been highlighted in this Industry Outlook article.


5 Biotech Stocks Worth Adding to Your Portfolio Now 

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, RGEN, IOVA, ARQT and PGEN in this volatile sector. 

Iovance Biotherapeutics Stock Is Trending Friday: What's Going On?

Shares of Iovance Biotherapeutics are trending Friday morning after a momentum surge pushed the biotech stock to a new 52-week high.read more...

Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? 

Equity

Strong results, clinical progress, capital raises and bullish analyst calls boosted investor confidence. 


IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism

UBS analyst David Dai raised the firm’s price target on IOVA to $7 from $4 on Thursday while maintaining a Neutral rating.


Why Iovance Biotherapeutics Stock Hit 52-Week High

Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amtagvi sales and analyst price target hikes.read more...

Here's Why Iovance Biotherapeutics (IOVA) is a Great Momentum Stock to Buy

Does Iovance Biotherapeutics (IOVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

IOVA Stock Hits New 52-Week High As Shares Jump 14% — What Drove The Rally? 

IOVA’s rally coincides with positive sentiment across melanoma-focused biotech stocks after Merck and Moderna announced successful late-stage data for their personalized mRNA cancer vaccine on Wednesday.


Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? 

Investors responded to clinical progress, improving commercial performance and new growth opportunities.


• Reported GAAP EPS of -$0.11 up 66.67% YoY
• Reported revenue of $198.63M up 231.31% YoY
• Iovance Biotherapeutics is reviewing its previously issued 2026 total revenue guidance of $350 million to $370 million based on strong second-quarter sales and current demand trends, with an update expected later.

Iovance Biotherapeutics reported a quarterly net loss and faces operational risks regarding manufacturing capacity expansion, while management cautioned that certain metrics may not reliably predict future Amtagvi revenue performance.

Iovance Biotherapeutics delivered record revenue and improved gross margins through strong Amtagvi demand and manufacturing efficiencies, while advancing its clinical pipeline with new FDA Fast Track Designations for novel therapies.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Stocktwits

Stocktwits Polls

Retail investors are observing a consistent pattern of high late-day volume and accumulation that suggests institutions are quietly building large positions.

The community is eagerly anticipating a catalyst through updated 2026 revenue guidance, widely expected to drop ahead of key upcoming investor conferences.

With high short interest and a heavily defensive sentiment, traders are speculating that any major positive catalyst could trigger a violent squeeze to double digits.

Long-term bulls are banking on the NSCLC trial and ongoing data readouts to transform the company's valuation beyond its current commercial stage.

Feed

News

Sentiment

Earnings

Fundamentals

Info

About IOVA